Cladribine for people with multiple sclerosis

To assess the efficacy and the safety of Cladribine in persons affected by any form of multiple sclerosis.

This is a protocol.

Health topics:

Neurology > Multiple sclerosis > Pharmacological treatments by drug type

Published:

24 January 2020

Authors:

Celani M, Melis M, Orso M, Ercolani M, Cantisani T

Primary Review Group:

Multiple Sclerosis and Rare Diseases of the CNS Group

See the full Review on

the Cochrane Library

►

Print
PDF
Citation
Celani M, Melis M, Orso M, Ercolani M, Cantisani T. Cladribine for people with multiple sclerosis. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No.: CD013524. DOI: 10.1002/14651858.CD013524

Don't show again

What role do you identify with the most?

General public, patient, or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.